Oxylipin concentrations in BALF from 1) Healthy controls 2) Asthmatic controls and 3) Asthmatics following provocation.

a<p>Polyunsaturated fatty acid.</p>b<p>Oxylipin levels are reported as concentration (pM) and were normalized to the BAL volume recoveries. A complete list of all oxylipin acronyms is provided in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033780#pone.0033780.s004" target="_blank">Table S1</a>.</p>c<p>Statistical significance was calculated with either an unpaired or paired Student's t-test. Values with p<0.05 are shown in italics with two significant figures.</p>d<p>The median concentration (pM) among the healthy controls (HC) regarding each oxylipin was used as a cut off limit for all three groups (<i>i.e.</i>, Healthy Controls, Asthmatic Controls and Asthmatics Following Provocation), with values provided in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033780#pone.0033780.s011" target="_blank">Table S8</a>. All p-values regarding trend are one-sided.</p>e<p>Average,</p>f<p>Coefficient of variance,</p>g<p>Arachidonic acid,</p>h<p>Linoleic Acid,</p>i<p>Dihomo-γ-linolenic acid,</p>j<p>α-Linolenic acid,</p>k<p>Eicosapentaenoic acid,</p>l<p>Docosahexaenoic acid.</p>m<p>15-Lipoxygenase products.</p>n<p>The numbers in parentheses indicate the number of oxylipin species analyzed for each subgroup.